Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Clin Immunol. 2009 Sep 30;133(3):428–436. doi: 10.1016/j.clim.2009.09.002

Table 2.

Estradiol uniquely downregulates signaling pathways in activated SLE T cells but not in normal T cells. Gene lists that were generated from microarray data were analyzed for pathways uniquely downregulated in all SLE T cells and not in the control T cells. List shown is of pathways which met the criteria for significance (p ≤ 0.05) in SLE T cells.

Pathway SLE T cells p-value Control T cells p-value
PPARα/RXRγ Activation 0.0006 NS
G-Protein Coupled Receptor Signaling 0.0017 NS
Hepatic Fibrosis/Hepatic Stellate Cell Activation 0.0019 NS
cAMP-mediated Signaling 0.0024 NS
Nitrogen Metabolism 0.0058 NS
Propanoate Metabolism 0.0102 NS
Circadian Rhythm Signaling 0.0120 NS
Axonal Guidance Signaling 0.0174 NS
Keratan Sulfate Biosynthesis 0.0234 NS
Calcium Signaling 0.0275 NS
Fatty Acid Metabolism 0.0282 NS
Valine, Leucine and Isoleucine Degradation 0.0309 NS
Cardiac β2-adrenergic Signaling 0.0324 NS
β-alanine Metabolism 0.0417 NS
Phospholipid Degradation 0.0417 NS
Synaptic Long Term Potentiation 0.0437 NS
LPS/IL-1 Mediated Inhibition of RXR Function 0.0437 NS
TGF-β Signaling 0.0447 NS
IL-2 Signaling 0.0457 NS
Amyloid Processing 0.0457 NS